Fig. 1From: Long-term effects of abatacept on atherosclerosis and arthritis in older vs. younger patients with rheumatoid arthritis: 3-year results of a prospective, multicenter, observational studyProportions of RA patients with the indicated EULAR responses. a Comparison between AY and CY groups. b Comparison between AO and CO groups. *p < 0.05. AO: older patients taking abatacept; AY: younger patients taking abatacept; CO: older patients taking conventional synthetic disease-modifying antirheumatic drugs; CY: younger patients taking conventional synthetic disease-modifying antirheumatic drugs; RA: rheumatoid arthritisBack to article page